Amanta Healthcare: To approve unaudited Financial Results for quarter and half year ended 30th September 2026
Amanta Healthcare (AMANTA) filed a disclosure titled "To approve unaudited Financial Results for quarter and half year ended 30th September 2026". The company is valued at about ₹670 crore.
What happened
Amanta Healthcare (AMANTA) filed a disclosure with the exchanges on 3 November 2026 at 05:16 PM titled "To approve unaudited Financial Results for quarter and half year ended 30th September 2026".
From the filing: "The Standalone Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2026. (Copy is enclosed herewith) 2."
Company snapshot
Amanta Healthcare is a micro-cap company, with a market value of about ₹670 crore.
The stock last traded at ₹172.5, against a 52-week range of ₹92–₹210 (17.9% below the high).
Before this filing the shares had moved −14.2% over the month and −3.2% over three months. Average daily turnover over the last 20 sessions was about ₹1.88 crore.
Promoters held 63.80% at the end of Q1 FY27, up 0.08% points from the previous quarter. Foreign institutions owned 0.43% and domestic institutions 12.92%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 65 | 3.5 | 1.22 |
| Q2 FY26 | 71 | 1.2 | 0.35 |
| Q3 FY26 | 74 | 4.6 | 1.35 |
| Q4 FY26 | 77 | 5.5 | 1.61 |
| Q1 FY27 | 69 | 3.3 | 0.85 |
What history shows
This is not the company's first results disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.
Market-wide, 10,321 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 3 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.